Completed PHASE1 INTERVENTIONAL 1-arm NCT04743414

Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects

A Phase 1 Open-Label Study to Assess the Effect of a Strong CYP3A4 Inhibitor, Itraconazole, on the Single Dose Pharmacokinetic Profile of CTP-543 in Healthy Adult Subjects

Sponsor: Concert Pharmaceuticals

Conditions Healthy Volunteers

Interventions CTP-543

Updated 5 times since 2021 Last updated: Apr 6, 2021 Started: Mar 2, 2021 Primary completion: Mar 27, 2021 Completion: Apr 5, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Volunteers and is currently completed. Concert Pharmaceuticals leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
May 2021 — Jul 2024 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Apr 2021 — May 2021 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Mar 2021 — Apr 2021 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Concert Pharmaceuticals

Data source: Concert Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Miami, United States